W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

NCT01929278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: CT Gel (clindamycin 1% and tretinoin 0.025%)
OTHER: Vehicle gel patch
OTHER: Blank patch

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]